Immunization, Hib3 in Côte d'Ivoire
Côte d'Ivoire: Immunization, Hib3 was 77.0% in 2024. ▬ Flat
Immunization, Hib3 in Côte d'Ivoire, 2009–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Côte d'Ivoire recorded 77.0% for immunization, hib3 in 2024.
Compared with earlier readings it is down 2.5% on the previous year and up 5.5% over ten years.
Over the whole period, immunization, hib3 in Côte d'Ivoire peaked at 87.0% in 2016 and was at its lowest, 62.0%, in 2011.
Côte d'Ivoire ranks 149th of 191 countries on this measure, in the bottom quarter.
Immunization, Hib3 in Côte d'Ivoire, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2009 | 81.0% | — |
| 2010 | 79.0% | -2.5% |
| 2011 | 62.0% | -21.5% |
| 2012 | 82.0% | +32.3% |
| 2013 | 75.0% | -8.5% |
| 2014 | 73.0% | -2.7% |
| 2015 | 79.0% | +8.2% |
| 2016 | 87.0% | +10.1% |
| 2017 | 83.0% | -4.6% |
| 2018 | 83.0% | +0.0% |
| 2019 | 79.0% | -4.8% |
| 2020 | 72.0% | -8.9% |
| 2021 | 73.0% | +1.4% |
| 2022 | 73.0% | +0.0% |
| 2023 | 79.0% | +8.2% |
| 2024 | 77.0% | -2.5% |
Côte d'Ivoire compared with similar countries
- Côte d'Ivoire's 77.0% is below the median for lower middle income countries, which is 84.0%, 92% of the median. (47 countries reporting)
- Côte d'Ivoire's 77.0% is below the median for Sub-Saharan Africa, which is 82.5%, 93% of the median. (48 countries reporting)
Biggest year-on-year movements
Years where Immunization, Hib3 in Côte d'Ivoire changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +32.3% | 62.0% | 82.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 81.0% | 81.0% | 81.0% | 1 |
| 2010s | 78.2% | 62.0% | 87.0% | 10 |
| 2020s | 74.8% | 72.0% | 79.0% | 5 |
Countries ranked near Côte d'Ivoire
More health data for Côte d'Ivoire
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7342 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 864.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 32,592 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 12 (2025)
- Population ages 00-04, female, annual growth rate 1.01 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0711 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Côte d'Ivoire?
- Immunization, hib3 in Côte d'Ivoire was 77.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Côte d'Ivoire?
- The highest recorded value was 87.0% in 2016.
- What is the lowest immunization, hib3 recorded in Côte d'Ivoire?
- The lowest recorded value was 62.0% in 2011.
- How does Côte d'Ivoire rank for immunization, hib3?
- Côte d'Ivoire ranks 149th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Côte d'Ivoire?
- Over the last ten years it is up 5.5%. The long-run trend across the full record is flat.
- Where does this Côte d'Ivoire data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.